Loading Runway...
Loading Runway...
Providers, payers, pharma, medtech — high consequence stakes slow but do not stop AI deployment.
healthcare exposure
11/100
-6 vs cross-industry
avg AI capability
43%
vs human baseline
healthcare deployment
1%
avg companies running AI for these tasks
velocity (QoQ)
+0.10pts/Q
deployment growth rate
We track 17 adoption signals and 104 capability evidence items across 17 tasks that define a business analyst’s work. Filtered to Healthcare, the data shows low exposure for now: deployment in this industry lags the broader market.
Compared to the cross-industry baseline (17/100), exposure in Healthcare is 6 points lower. This industry is moving slower than the average — but that gap typically narrows once a category lead emerges.
Change Impact Assessment
1% of healthcare companies deploying AI · capability at 28% of human baseline
Wireframing & Prototyping
2% of healthcare companies deploying AI · capability at 60% of human baseline
KPI & Metrics Definition
2% of healthcare companies deploying AI · capability at 55% of human baseline
Backlog Management & Prioritisation
2% of healthcare companies deploying AI · capability at 47% of human baseline
Post-Implementation Review
1% of healthcare companies deploying AI · capability at 47% of human baseline
See where your tasks stand — not the average.
Take a free task-level assessment. 8 minutes, evidence-backed, with a personalised brief.
Take the assessment →